There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and the resulting economic uncertainty. Hospitals are ...

A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic are resolved. Consequently, compounding pharmacies must stop making their ...

When digital musculoskeletal company Hinge Health launched about a decade ago, it primarily targeted employers directly. However, in recent years, it has expanded its health plan partnerships and ...

You arrive at the scene to find a patient struggling to breathe. They can’t speak clearly, no family is present, and no one knows their medical history. What medications are they on? Do they ...

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. The device is an atrio-ventricular interval modulation therapy, meaning it ...

Contraline — a trailblazer in the nascent male contraceptive market — released promising new trial data on Thursday showing that the company’s contraceptive hydrogel has demonstrated safety ...

Substance use disorder (SUD) remains a costly and dangerous public health challenge that affects over 48 million people in the US annually. High relapse rates, typically 40-60%, lead me to believe ...

In 2010, the Affordable Care Act redefined access to healthcare. Fifteen years later, we find ourselves facing a different kind of challenge — not who can enter the system, but how the system ...

The connection between climate and physical health is evident. We know, for instance, that asthma is exacerbated by exposure to wildfire smoke that occurs more commonly during hot, dry, windy ...

Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the year and the start of clinical testing in an autoimmune disease. The CRISPR ...